Tips and Tricks to Treat Central Lung Tumors with the CyberKnife® System
Dr. Nuyttens will share his 15 years of experience in treating lung lesions with the CyberKnife System. He will focus on how effectively central lung tumors can be treated, the challenges faced and how he manages to deliver the most effective dose. Dr. Nuyttens will show actual cases, planning, dose constraints and clinical outcomes.
Planning with the CyberKnife® VOLO™ Optimizer: Hear from the experts
In this webinar the presenters will share their approach to planning brain metastases, lung tumors, and prostate tumors using the VOLO optimizer. This will be followed by a moderated Q&A session.
CyberKnife® Radiosurgery for AVMs: Using High-Definition Rotational Angiographic Imaging
This webinar aims to emphasize the essential technical aspects of Radiosurgery for AVMs, and to highlight the inclusion of precise angiographic information that may likely help in better patient outcomes with the CyberKnife® System.
Challenges in Clinical Small Field Dosimetry Using the CyberKnife®
Dr. Paolo Francescon, Vicenza, Italy
Clinical Results After Single-fraction Radiosurgery for 1,002 Vestibular Schwannomas
Prof. Alexander Muacevic is the medical director of the European CyberKnife Center in Munich, Germany. He holds an academic teaching position at the University of Munich Hospitals. His main clinical and scientific interest is full body radiosurgery using advanced image-guided robotic technology. He is a trained and board certified neurosurgeon and radiosurgeon. In addition, he holds a European Neurosurgery Certificate. He has published over 100 scientific contributions such as full papers, book chapters and congress proceedings. Alexander Muacevic is member of several academic societies and the president of the International Radiosurgery Society which has over 700 members. He is co-founder and the co-chief editor of Cureus.com.
Treatment of Pancreas Cancer with the CyberKnife® System
After graduating from Madras Medical College in India, Dr. Anand Mahadevan completed his surgical and oncology training in the UK. After a 2-year fellowship in the Harvard Radiation Oncology program, he went on to become a staff radiation oncologist at the Beth Israel Deaconess Medical Center, Harvard Medical School faculty and Assistant Program director of the Harvard Radiation Oncology Program. He is currently the Professor and Chairman of Radiation Oncology at the Geisinger Health System. His clinical interests and contributions are primarily in Stereotactic radiation to Liver and Pancreatic tumors, Oligometastasis and NeuroOncology.
Multifraction SRS in the Treatment of Large Brain Oligometastases
Dr. Zhu is an attending physician of Neurosurgery at Huashan Hospital in Shanghai. His main research interests are in stereotactic radiosurgery, treatment of oligometastatic large brain tumor and skull based tumor. Dr. Zhu also leads several clinical trials. He is a regular presenter at meetings of the International Stereotactic Radiosurgery Society.
Intensity-Modulated Fractionated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Findings from an International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): Acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Dr. Nicholas van As is the Medical Director of the Royal Marsden Hospital, Consultant Clinical Oncologist in the Urology Unit, and a Reader at the Institute of Cancer Research.
CyberKnife® System Experience for Partial Breast Irradiation
Dr. Rahimi is an Associate Professor of Radiation Oncology at UT Southwestern Medical Center and focuses on breast radiation. She is also the Director of Clinical Research for the Department of Radiation Oncology and oversees more than 100 clinical trials in the department. Dr. Rahimi has focused her clinical research on developing stereotactic partial breast irradiation techniques for early stage breast cancer.
An overview of the Medicare Radiation Oncology Alternative Payment Model 2020 Proposed Rule
Shawn Prince, MBA is the Senior Director, Patient Access at Accuray Incorporated.
